Oct 4, 2016 7:03 am EDT Abeona Therapeutics to Present at Jefferies Gene Editing & Gene Therapy Summit
Sep 26, 2016 7:03 am EDT Abeona Therapeutics Enrolls First Patient in Phase 2 for EB-101 Gene Therapy Clinical Trial for Epidermolysis Bullosa
Sep 23, 2016 7:03 am EDT Abeona Therapeutics to Present at Ladenburg Thalmann 2016 Healthcare Conference
Sep 21, 2016 7:03 am EDT Abeona Therapeutics Announces Licensing of the AIM(TM) Next Generation AAV Gene Therapy Vector Platform From The University of North Carolina at Chapel Hill
Sep 15, 2016 7:03 am EDT Abeona Therapeutics Announces Publication of Preclinical Data Supporting Clinical Translation of MPS IIIA Gene Therapy
Sep 8, 2016 7:03 am EDT Abeona Therapeutics Enrolls 5th Patient in Phase 1/2 Gene Therapy Clinical Trial for Epidermolysis Bullosa
Sep 7, 2016 7:03 am EDT Abeona Therapeutics to Present at Rodman & Renshaw 18th Annual Global Investment Conference
Sep 1, 2016 7:03 am EDT Abeona Therapeutics to Present at Landmark Angels 6th Annual Investing for Cures 2016 Conference
